J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK)
J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.
UBS Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)
UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...
GSK rises Wednesday, outperforms market
Shares of GSK PLC GSK inched up 0.94% to £14.01 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.28% to 8,557.81. GSK ...
Despite A Promising Future For Hutchmed, We Have Concerns About Development Of The Share Price (Rating Downgrade)
Hutchmed expects to record a gain of $477m from the deal and plans to invest the proceeds to develop its internal pipeline. See why I rate HCM stock a Hold.
Rylan Clark ‘honoured’ to be announced as first ever host of 2025 Metro Pride Awards
Rylan Clark has shared his ‘honour’ at being announced as the host of the 2025 Metro Pride Awards. The TV icon will be taking on presenting duties at the star-studded event in London on 26 February, ...
Le Lézard23h
Arcadis secures $150MM indefinite delivery, multiple-award task order contract with USACE Tulsa District
Arcadis, a global leader in intelligence-driven sustainable design, engineering, and consultancy solutions for natural and built assets, announced today that it has been awarded a $150 million ...